AstraZeneca insists that its COVID-19 vaccine is strongly effective even after counting additional illnesses in its U.S. study.
The coronavirus vaccine made by AstraZeneca is set to be reviewed for possible use in the United States soon.
Results from a U.S. trial of AstraZeneca’s COVID-19 vaccine may have used “outdated information,” U.S. federal health officials said…
AstraZeneca released results from its United States phase three vaccine trial Monday, saying it’s 79% effective in preventing symptomatic COVID-19 and 100% effective at preventing severe disease and hospitalization.
More countries suspending use of AstraZeneca vaccine following some reports of potentially dangerous side effects
A growing number of countries have suspended injections of AstraZeneca’s COVID-19 vaccine, to investigate some possibly dangerous side effects. Officials say there have been reports of blood clots, bleeding and even death in a very small number of people who received injections of the AstraZeneca vaccine.
The World Health Organization has granted an emergency authorization to the coronavirus vaccine made by AstraZeneca and Oxford University.
The developers of AstraZeneca’s coronavirus vaccine say the shot appears to work against the variant detected in Britain.
Scientists in the United Kingdom believe a new vaccine may slow down transmission of the coronavirus.
The British government says regulators have just approved the Oxford-Astrazeneca coronavirus vaccine.
New results on a possible COVID-19 vaccine from Oxford University and drugmaker AstraZeneca suggest it is safe and about 70% effective.